Oral solid dosage is still the preferred method of drug delivery, however, the patient’s experience when taking medication can mean they adhere to the regimen or not. Here, Dr Brian Wilson and Dr Graeme MacLeod from SPI Pharma look at the challenges
In this online exclusive, Stephanie Ward, a quality assurance engineer at technology and product design firm Cambridge Design Partnership looks at the new European MDR in more detail and the impact these may have on manufacturers
Tablet manufacturing poses many challenges and the development process of a tablet form is a critical step that requires the correct tools and equipment. In this article, Robert Sedlock, Natoli Engineering will discuss the three phases
The Association of the British Pharmaceutical Industry (ABPI) has released research showing that the amount of capital invested alongside corporate venture capital (CVC) in UK biotech increased six-fold between 2010 and 2015.
In this online exclusive, Sean Riley, global industry director for manufacturing and transportation at Software AG discusses five manufacturing trends that are expected in 2018.
Results from a major survey have demonstrated that manufacturers in the UK are experiencing improved global demand, from European markets in particular, despite the current political uncertainty.
STA Pharmaceutical has reported rapid growth in companies intending to market their products in China using it as a partner following the CFDA announcement of the Market Authorization Holder (MAH) pilot programme last year
Despite concern expressed by the pharmaceutical industry that the UK would suffer as a result of Brexit, Catalyst Corporate Finance, the UK business of Alantra, argues that the UK’s decision to leave the European Union in fact
The RSA Group, has published a new study analysing the performance of biotechnology boards, CEOs and chairs from both Europe and the US, from an investor viewpoint, demonstrating that European companies are outperforming US ones
Research from the Fraser of Allander Institute (FAI), mapping out the economic contribution of Scotland’s pharmaceutical sector, has been released by the Association of the British Pharmaceutical Industry (ABPI) Scotland.
Today (Monday 27 November) marks the original deadline date for the DSCSA. While the FDA has delayed its enforcement of compliance with these serialisation requirements by a year, pharma is still required to legally comply. Industry tells us more…
Following the chancellor’s autumn budget announcement, we provide a brief round-up of the key points and some of the reactions from the pharma and industry leaders.
